<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Prieux-Klotz C</submitter><funding>Fondation de la maison de la chimie for P.R.S. postdoctoral fellowship</funding><pagination>12938</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9658974</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(21)</volume><pubmed_abstract>Reactive oxygen species (ROS) are produced by every aerobic cell during mitochondrial oxidative metabolism as well as in cellular response to xenobiotics, cytokines, and bacterial invasion. Superoxide Dismutases (SOD) are antioxidant proteins that convert superoxide anions (O&lt;sub>2&lt;/sub>&lt;sup>•-&lt;/sup>) to hydrogen peroxide (H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub>) and dioxygen. Using the differential in the level of oxidative stress between normal and cancer cells, SOD mimetics can show an antitumoral effect and prevent oxaliplatin-induced peripheral neuropathy. New Pt(IV) conjugate prodrugs (OxPt-x-Mn1C1A (x = 1, 1-OH, 2)), combining oxaliplatin and a Mn SOD mimic (MnSODm Mn1C1A) with a covalent link, were designed. Their stability in buffer and in the presence of sodium ascorbate was studied. In vitro</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>A New Manganese Superoxide Dismutase Mimetic Improves Oxaliplatin-Induced Neuropathy and Global Tolerance in Mice.</pubmed_title><pmcid>PMC9658974</pmcid><funding_grant_id>ANR-16-CE18-0017-01</funding_grant_id><pubmed_authors>Prieux-Klotz C</pubmed_authors><pubmed_authors>Nicco C</pubmed_authors><pubmed_authors>Chene C</pubmed_authors><pubmed_authors>Policar C</pubmed_authors><pubmed_authors>Coriat R</pubmed_authors><pubmed_authors>Zoumpoulaki M</pubmed_authors><pubmed_authors>Bertrand HC</pubmed_authors><pubmed_authors>Batteux F</pubmed_authors><pubmed_authors>Thomas M</pubmed_authors><pubmed_authors>Ranjan Sahoo P</pubmed_authors><pubmed_authors>Lopez-Sanchez A</pubmed_authors><pubmed_authors>Chedotal H</pubmed_authors><pubmed_authors>Chouzenoux S</pubmed_authors></additional><is_claimable>false</is_claimable><name>A New Manganese Superoxide Dismutase Mimetic Improves Oxaliplatin-Induced Neuropathy and Global Tolerance in Mice.</name><description>Reactive oxygen species (ROS) are produced by every aerobic cell during mitochondrial oxidative metabolism as well as in cellular response to xenobiotics, cytokines, and bacterial invasion. Superoxide Dismutases (SOD) are antioxidant proteins that convert superoxide anions (O&lt;sub>2&lt;/sub>&lt;sup>•-&lt;/sup>) to hydrogen peroxide (H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub>) and dioxygen. Using the differential in the level of oxidative stress between normal and cancer cells, SOD mimetics can show an antitumoral effect and prevent oxaliplatin-induced peripheral neuropathy. New Pt(IV) conjugate prodrugs (OxPt-x-Mn1C1A (x = 1, 1-OH, 2)), combining oxaliplatin and a Mn SOD mimic (MnSODm Mn1C1A) with a covalent link, were designed. Their stability in buffer and in the presence of sodium ascorbate was studied. In vitro</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2026-06-20T03:25:07.184Z</modification><creation>2025-04-19T13:22:49.506Z</creation></dates><accession>S-EPMC9658974</accession><cross_references><pubmed>36361753</pubmed><doi>10.3390/ijms232112938</doi></cross_references></HashMap>